Showing 781-790 of 1518 results for "".
Andrew F. Alexis, MD, MPH
https://practicaldermatology.com/topics/general-topics/andrew-f-alexis-md-mph/21369/Pearls for Choosing and Initiating Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0309_18-php/22872/Members of the psoriasis panel at the 2009 South Beach Symposium last month offered insights on patient care.2019 In Review
https://practicaldermatology.com/topics/practice-management/2019-in-review/23168/A look back at approvals, data, and industry developments of the year.How Epidermolysis Bullosa Treatments Went from Blisters to Breakthroughs
https://practicaldermatology.com/topics/rare-disease/how-epidermolysis-bullosa-treatments-went-from-blisters-to-breakthroughs/54391/Current FDA-approved therapies oleogel-S10, beremagene geperpavec, and prademagene zamikeracel represent major therapeutic breakthroughs for the treatment of epidermolysis bullosa (EB). Earlier systemic intervention, improved nutrition, and proactive management of complications have extended survivThe Gender Gap in Dermatology: Where Are We Now?
https://practicaldermatology.com/topics/general-topics/the-gender-gap-in-dermatology-where-are-we-now/20820/Despite advances, women are still not equally represented in academic dermatology or dermatology leadership.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20614/Exploring the Connection Between Gut Health and Hair
https://practicaldermatology.com/issues/supplements/exploring-the-connection-between-gut-health-and-hair/23089/Sponsored by Nutrafol®Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-18/23367/Keratosis Pilaris: A Rough and Bumpy Review
https://practicaldermatology.com/columns/clinical-focus-1/keratosis-pilaris-a-rough-and-bumpy-review/23618/There are promising interventions for this challenging presentation.Look to the EAST: Shared Decision Making in the Era of New Therapies
https://practicaldermatology.com/topics/atopic-dermatitis/look-to-the-east-shared-decision-making-in-the-era-of-new-therapies/23372/Assessing Efficacy, Accessibility, Safety, and Tolerability is the key to a meaningful dialogue with patients.